@drtomslens · Long HIMS

$HIMS: Morpheus was willing to look wrong for years. Agent Smith couldn’t imagine being wrong for even a second. Guess who won.

Tomislav Marinovic@DrTomsLens

Very important update for $HIMS and its upcoming peptide business. Yesterday, the FDA submitted an Interim Access Policy for Compounding Using Certain Peptides for regulatory review. Remember, back in July, an FDA advisory committee recommended allowing compounding of six

Read asLong HIMS

Since the call—

unrankedThe analyst's rank today

Medium · 0.86Confidence

Thu, Oct 15Tweeted

Fri, Oct 16 closeCounted from

1% of the basket · day 0fades out by Nov 26

Rank per close

Counts from the Fri, Oct 16 close, which is not scored yet.